Cantor Fitzgerald maintains Home BancShares at Neutral, raises price target to $32 from $31

Cantor Fitzgerald kept Home BancShares at Neutral but increased its price target to $32, a 3.2% rise from the previous $31. This suggests a 7.2% upside from the Nov 6 closing price of $29.86, according to the firm.

Original reporting
Published Nov 9, 2026, 12:04 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 9, 2026, 12:12 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Cantor Fitzgerald maintains Home BancShares at Neutral, raises price target to $32 from $31 — source image
Decision brief

The 30-second read

$HOMBBullishMed
01

Why it matters

The upgrade signals a modest upside, but limited trading volume may constrain price movement.

02

Market read

A small but actionable catalyst for HOMB; limited broader market impact.

03

What to watch

Potential credit quality concerns in the bank's loan portfolio are not addressed.

Relevance 5/10Novelty 5/10Timing: today

Background

Home BancShares (NASDAQ:HOMB) is a regional bank; analyst price target updates are common catalysts for small-cap equities.

Company-level read

Ticker impact

$HOMBBullishMedium confidence
Context

Cantor Fitzgerald raised its price target for Home BancShares to $32 from $31, indicating a fresh bullish outlook.

Expected impact

likely upward pressure as investors price in the higher target

Evidence & confidence

The new target suggests ~7% upside from recent close; traders may add positions anticipating price appreciation.

Market effects

Minimal; reflects broader optimism in regional banking sector.

Slight positive bias for U.S. community banks.

Low; limited to investors tracking small-cap banks.

Counterpoint

Target raise may be premature if macro pressures on rates persist.

Key entities

  • Cantor Fitzgerald

    Equity research firm that issued the price target raise.

  • Home BancShares

    Regional bank whose stock is the subject of the analyst update.

Related articles

$HOMBMed

Home BancShares (HOMB) Q3 2026 Earnings Call Transcript

Home BancShares (HOMB) reported Q3 2026 earnings, highlighting a 9.5% dividend increase to $0.23/share, $39.3M in share buybacks (0.69% yield), and strong profitability. The company emphasized its disciplined balance sheet strategy, avoiding long-duration securities, and managing AOCI impact. Key metrics include a 4.53% net interest margin, 2.11% ROA, and 16.54% return on tangible common equity. Management expects recoveries on a large nonperforming loan and plans continued stock repurchases.

$HOMBMed

Piper Sandler lowers Home Bancshares price target to $34 on growth

Piper Sandler cut its price target on Home Bancshares (HOMB) to $34 from $36, citing Q3 2026 results that beat EPS estimates but showed loan and deposit declines. The firm adjusted EPS estimates for 2026-2028, highlighting improved net interest margin and share repurchases. HOMB reported record Q3 earnings of $129.1M ($0.65 EPS), beating estimates, but revenue missed expectations. Analysts focus on strong profitability and capital levels.

$HOMBMed

Home BancShares (HOMB) Q3 Results Meet Record Profit While Credit Risk Builds

Home BancShares (HOMB) reported Q3 results meeting record profits, with $850M in loan production and a 4.53% margin. Management is cautiously optimistic about Q4 growth but acknowledges volatility in loan demand and deposit competition. Concerns include unpredictable loan payoffs and reliance on acquisitions for growth. The company's stock is discussed in the context of potential mispricing.

$HOMBMed

Home BancShares Q3 Earnings Call Highlights

Home BancShares (HOMB) reported Q3 earnings, including a 9.5% dividend increase to $0.23 per share and $39.3M in share repurchases. The company expects to complete Mountain Commerce integration by Q4, with $5M in annualized cost savings. Loan production was $850M, with loan growth expected to improve. Legacy deposits declined by $358M. Management anticipates resolving a large Texas C&I nonaccrual credit, potentially recovering $10M.